The Tandem 4.0 augmented reality-enhanced collaboration tool from Apprentice.io has a new user experience and user interface design.
Apprentice.io released Tandem 4.0, an updated version of its augmented reality-enhanced collaboration tool for pharma and manufacturing industries that can be used in lab, line, and suite environments. The updated platform includes augmented reality capabilities and a refined user experience/user interface (UX/UI) design. Users can connect globally and problem-solve in real-time, helping organizations avoid deviations and prevent manufacturing delays.
The company reports that the new UX/UI design for smart glass Tandem sessions is more intuitive, with redesigned screens, text, and icons for improved navigation. Customized user menus have been incorporated, and voice commands have been leveraged to better guide users through processes. In addition, users receive application feedback during critical interactions.
Interactions are enhanced with new capabilities in the company’s ARKit solution. For example, single- or multi-user drawing annotations can now be made on a captured image. For direct, live support, remote experts can use a laser pointer to assist users as they complete a task. Remote experts can also bring attention to a specific area or a part of machinery by dropping 3D augmented reality arrows in an operator’s real-world environment. Tandem sessions can be conducted between operators and subject matter experts across any device. Depending on an individual's comfort level or work-flow, users can stream sessions from iOS, phones, or tablets.
Source: Apprentice.io.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.